“Re-educating” tumor-associated macrophages by targeting NF-κB
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The nuclear factor κB (NF-κB) signaling pathway is important in cancer-related inflammation and malignant progression. Here, we describe a new role for NF-κB in cancer in maintaining the immunosuppressive phenotype of tumor-associated macrophages (TAMs). We show that macrophages are polarized via interleukin (IL)-1R and MyD88 to an immunosuppressive “alternative” phenotype that requires IκB kinase β–mediated NF-κB activation. When NF-κB signaling is inhibited specifically in TAMs, they become cytotoxic to tumor cells and switch to a “classically” activated phenotype; IL-12high, major histocompatibility complex IIhigh, but IL-10low and arginase-1low. Targeting NF-κB signaling in TAMs also promotes regression of advanced tumors in vivo by induction of macrophage tumoricidal activity and activation of antitumor activity through IL-12–dependent NK cell recruitment. We provide a rationale for manipulating the phenotype of the abundant macrophage population already located within the tumor microenvironment; the potential to “re-educate” the tumor-promoting macrophage population may prove an effective and novel therapeutic approach for cancer that complements existing therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. IKKβ inhibition increases macrophage tumoricidal activity. (A) WT, MyD88−/−, TLR-2−/−, and TLR-4−/− or mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8-Luc in a modified Boyden chamber without direct cell–cell contact for 72 h. In addition, CD11b+-selected TAMs from the ascites of ID8 tumor–bearing mice were mock (TAMmock) or IKKβDN infected (TAMDN). Invasion of ID8-Luc cells was assessed by luciferase activity in the lower part of the chamber. Macrophages deleted in MyD88, IL-1R, or IKKβ significantly reduce ID8-Luc invasion (P < 0.01; t test with Welch's correction). Data are represented as mean ± SEM of n = 6. Representative data are shown from at least three independent experiments. (B) ID8 cells were co-cultured with IKKβ-targeted BMDMs or TAMs and respective control cells. Fluorescence caspase 3/7 activity was assessed after 0, 3, and 6 h. Co-culture with IKKβDN and IKKβΔ BMDMs or TAMs expressing IKKβDN (TAMDN) significantly increases caspase 3/7 activity in ID8 cells (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 6. Representative data are shown from at least three independent experiments. (C) [111In]oxine release assay after a 24-h co-culture of 111In-labeled ID8 cells with mock, IKKβDN, TAMDN or IKKβf/f, and IKKβΔ macrophages. 111In-release in cell-free culture supernatants was measured after 24 h with a scintillation counter. IKKβ-targeted macrophages promote increased cytotoxicity. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.](https://figures.cochat.ai/paper-figures/741fab83e5184295af0f590a594611ed/re-educating-tumor-associated-macrophages-by-targeting-nf-b-figure-1.jpg)
![Figure 2. IKKβ maintains the alternative phenotype of tumor-polarized macrophages. WT, mock, IKKβDN or IKKβf/f, and IKKβΔ BMDMs were co-cultured with ID8 cells for 24 h. Supernatant was collected after 24 h and analyzed for IL-10, IL-12p70, TNF-α, and NO production by ELISA. (A) Co-cultured WT macrophages express an immunosuppressive IL-10high IL-12p70low TNF-αhigh profile. However, supernatant from co-cultured IKKβ-deleted macrophages show a significant decrease in IL-10 and TNF-α (P < 0.01; t test with Welch's correction) but increase in IL-12p70 (P < 0.01; t test with Welch's correction). Data are represented as mean ± SD of n = 3. Representative data are shown from at least three independent experiments. (B) In parallel, total RNA was isolated for real-time PCR analysis of IL-12p40 and arginase-1 in co-cultured macrophages. Targeting IKKβ in macrophages switches their phenotype to an IL-12high arginase-1low NOS2high profile, consistent with an M1 phenotype. In_addition, IKKβ-targeted macrophages secrete significantly higher levels of NO, measured as nitrite by Griess assay (P < 0.01; Mann-Whitney test). Data are represented as mean ± SD of n = 3. Representative data are shown from at least four independent experiments. (C) Macrophages were co-cultured with ID8 cells, and protein extracts were prepared at the indicated time points for biochemical analysis. Expression of NF-κB p65, serine 536 phosphorylation of p65, IKKβ, Stat1, tyrosine 701 phosphorylation of Stat1 (Tyr701), and NOS2 was measured by immunoblot analysis of cell lysates using β-actin as a loading control. Representative data are shown from at least three independent experiments. (D) [111In]oxine release assay after co-culture of ID8 ovarian cancer cells with IKKβDN or IKKβΔ BMDMs. IKKβ-targeted macrophages promote increased cytotoxicity that was reversed by the addition of the selective NOS2 inhibitor 1400W. Data are represented as mean of n = 3. Representative data are shown from at least three independent experiments.](https://figures.cochat.ai/paper-figures/2ca0616e0f4f417d8bd81ac7dc101f6c/re-educating-tumor-associated-macrophages-by-targeting-nf-b-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
Xie, Q.-W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., & Nathan, C. (1992) · Science · doi:10.1126/science.1373522 · Cited by 1,886
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Self-citationColony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018
Cited by
Items 401–500 of 802
Валерьевич, К. С., Lyamina, S., Усанова, Е. А., Manukhina, E. B., Np, L., & Malyshev, I. Y. (2015) · Medical science monitor basic research/Medical science monitor. Basic research · doi:10.12659/msmbr.895563 · Cited by 44
Miao, L., Holley, A. K., Zhao, Y., Clair, W. H. S., & Clair, D. K. S. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5637 · Cited by 44
“IR generates highly reactive free radicals, and it has been well documented that stromal components, such as cancer-associated fibro-blasts (CAFs), tumor-associated macrophages (TAMs), and endothelial cells, enhance oxidative stress, which promotes tumor progression (2, 50).”
BackgroundTherapeutically reeducating macrophages to treat GBM
Garris, C., & Pittet, M. J. (2013) · Nature Medicine · doi:10.1038/nm.3355 · Cited by 43
Tumor-Associated Macrophages as Targets for Tumor Immunotherapy
Weigert, A., Sekar, D., & Brüne, B. (2008) · Immunotherapy · doi:10.2217/1750743x.1.1.83 · Cited by 45
Collaborating with the Enemy: Function of Macrophages in the Development of Neoplastic Disease
Eljaszewicz, A., Wiese‐Szadkowska, M., Helmin–Basa, A., Jankowski, M., Gackowska, L., Kubiszewska, I., Kaszewski, W., Michałkiewicz, J., & Zegarski, W. (2013) · Mediators of Inflammation · doi:10.1155/2013/831387 · Cited by 41
Acetyl- l -carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways
Baci, D., Bruno, A., Bassani, B., Tramacere, M., Mortara, L., Albini, A., & Noonan, D. M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.018 · Cited by 44
Prognostic role of immune infiltrates in breast ductal carcinoma in situ
Chen, X., Yeong, J. P.-S., Thike, A. A., Bay, B., & Tan, P. H. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05272-2 · Cited by 46
Habanjar, O., Diab‐Assaf, M., Caldefie‐Chezet, F., & Delort, L. (2022) · Biology · doi:10.3390/biology11020339 · Cited by 45
Schmieder, A., Schledzewski, K., Michel, J., Tuckermann, J. P., Tome, L., Sticht, C., Gkaniatsou, C., Nicolay, J. P., Demory, A., Faulhaber, J., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25657 · Cited by 58
The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
Khabele, D. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00111 · Cited by 42
“Our group and others have shown that macrophages are abundant in peritoneal ascites fluid and that ovarian tumors have the ability to polarize macrophages to display tumor-promoting characteristics in a nuclear factor-kappaB (NF-κB)-dependent manner (84, 90), but can be “re-educated” toward an anti-tumor phenotype (84…”
BackgroundWeber, C., Telerman, S. B., Reimer, A. S., Sequeira, I., Liakath‐Ali, K., Arwert, E. N., & Watt, F. M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-14-3676 · Cited by 42
Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma
Pandey, V., & Störz, P. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1622417 · Cited by 41
Murphy, C. E., Walker, A. K., O׳Donnell, M., Galletly, C. A., Lloyd, A. R., Liu, D., Weickert, C. S., & Weickert, T. W. (2022) · Translational Psychiatry · doi:10.1038/s41398-021-01764-2 · Cited by 44
“Macrophages lacking IKKβ may therefore maintain a proinflammatory M1-like phenotype with sustained cytokine release once inside tissue and fail to switch to an M2 anti-inflammatory state [73, 74].”
BackgroundHou, Y., Liu, M., Husted, C. I., Chen, C.-H., Thiagarajan, K., Johns, J. L., Rao, S. P., & Alvira, C. M. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00029.2015 · Cited by 41
“NF- B enhances the formation of collateral vessels after ischemia by increasing the accumulation of M2 macrophages (60) and is necessary for maintaining the M2-phenotype of tumor associated macrophages (25).”
BackgroundZhang, T., Ma, Z., Wang, R., Wang, Y., Wang, S., Cheng, Z., Xu, H., Jin, X., Li, W., & Wang, X. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0836-y · Cited by 42
“Both studies suggested that by targeting IKK to block NF- B activity, TAM was polarized toward the M1 phenotype [43, 44].”
BackgroundClinical significance of macrophage phenotypes in cardiovascular disease
Medbury, H. J., Williams, H., & Fletcher, J. (2014) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0042-1 · Cited by 44
Macrophage’s role in solid tumors: two edges of a sword
Jahandideh, A., Yarizadeh, M., Masjedi, M. N.-K., Fatehnejad, M., Jahandideh, R., Soheili, R., Eslami, Y., Zokaei, M., Ahmadvand, A., Ghalamkarpour, N., et al. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02999-3 · Cited by 40
The Regulatory Network of Transcription Factors in Macrophage Polarization
Liu, J., Wang, M., & Zhao, Y. X. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s494550 · Cited by 41
Kono, Y., Kawakami, S., Higuchi, Y., Yamashita, F., & Hashida, M. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00659 · Cited by 40
Principles of Modular Tumor Therapy
Reichle, A., & Hildebrandt, G. C. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0023-x · Cited by 39
Breasson, L., Becattini, B., Sardi, C., Molinaro, A., Zani, F., Marone, R., Botindari, F., Bousquenaud, M., Rüegg, C., Wymann, M. P., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaf2969 · Cited by 42
“By contrast, others propose that NF-kB activity in macrophages promotesM2macrophage polarization andmaintains an immunosuppressing phenotype in tumor-associatedmacrophages (38, 39).”
BackgroundMorón-Calvente, V., Romero-Pinedo, S., Toribio-Castelló, S., Plaza‐Díaz, J., Abadía‐Molina, A. C., Rojas-Barros, D. I., Beug, S. T., LaCasse, E. C., MacKenzie, A., Korneluk, R. G., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193643 · Cited by 40
Yang, J., Kantrow, S. M., Sai, J., Hawkins, O. E., Boothby, M. R., Ayers, G. D., Young, E. D., Demicco, E. G., Lazar, A. J., Lev, D. C., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0440 · Cited by 43
Macrophage Subset Sensitivity to Endotoxin Tolerisation by Porphyromonas gingivalis
Foey, A., & Crean, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067955 · Cited by 46
Differentiation of the Mammary Epithelial Cell during Involution: Implications for Breast Cancer
Monks, J., & Henson, P. M. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9121-0 · Cited by 42
“[53]”
Mechanism of the Antitumor and Radiosensitizing Effects of a Manganese Porphyrin, MnHex-2-PyP
Shin, S.-W., Choi, C., Lee, G.-H., Son, A.-R., Kim, S.-H., Park, H. C., Batinic̈‐Haberle, I., & Park, W. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6889 · Cited by 38
“The effect on M1 may also be NF-κB controlled (22).”
Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer
Glass, E. B., Hoover, A., Bullock, K. K., Madden, M. Z., Reinfeld, B. I., Harris, W., Parker, D., Hufnagel, D. H., Crispens, M. A., Khabele, D., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09612-2 · Cited by 42
Bao, B., Thakur, A. B., Li, Y., Ahmad, A., Azmi, A. S., Banerjee, S., Kong, D., Ali, S. S., Lum, L. G., & Sarkar, F. H. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.11.002 · Cited by 40
GADD45β Loss Ablates Innate Immunosuppression in Cancer
Verzella, D., Bennett, J., Fischietti, M., Thotakura, A. K., Recordati, C., Pasqualini, F., Capece, D., Vecchiotti, D., D’Andrea, D., Francesco, B. D., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1833 · Cited by 41
“28 mimicking the tumour-cell/macrophage interactions occuring in cancer, in vivo (18).”
BackgroundMethodSelf-citationTumor‐derived exosomal microRNAs and proteins as modulators of macrophage function
Moradi‐Chaleshtori, M., Hashemi, S. M., Soudi, S., Bandehpour, M., & Mohammadi‐Yeganeh, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27552 · Cited by 38
“Therefore, it induces protumoral and immunosuppressive effects (Hagemann et al., 2008).”
Li, L., Yang, L., Yang, S., Wang, R., Gao, H., Lin, Z., Zhao, Y., Tang, W., Han, R. F., Wang, W., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7578 · Cited by 37
“Therefore, those agents which re-polarize macrophages or regulate their secreted cytokines should have the potential to be the drug candidates in cancer therapy (Hagemann et al., 2008).”
BackgroundYeast β-glucan modulates macrophages and improves antitumor NK-cell responses in cancer
Zhu, Z., He, L., Bai, Y., Xia, L., Sun, X. Y., & Qi, C. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad080 · Cited by 38
Ahlers, J. D., & Belyakov, I. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.007 · Cited by 45
Komohara, Y., Takemura, K., Lei, X., Sakashita, N., Harada, M., Suzuki, H., Kodama, T., & Takeya, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01296.x · Cited by 38
Immune Control in Hepatocellular Carcinoma Development and Progression: Role of Stromal Cells
Sprinzl, M. F., & Galle, P. R. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1394138 · Cited by 38
Using curcumin to turn the innate immune system against cancer
Mukherjee, S., Baidoo, J., Fried, A., & Banerjee, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113824 · Cited by 37
Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer
Husain, K. M., Williamson, T. T., Nelson, N., & Ghansah, T. (2020) · Immunological Medicine · doi:10.1080/25785826.2020.1843267 · Cited by 37
Wu, J., Shen, S., Liu, T., Ren, X., Zhu, C., Liang, Q., Cui, X., Chen, L., Cheng, P., Cheng, W., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02295-w · Cited by 38
Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model
Wilson, A. J., Barham, W. J., Saskowski, J. L., Tikhomirov, O., Chen, L., Lee, H., Yull, F. E., & Khabele, D. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-63 · Cited by 40
“Pro-inflammatory cytokines and chemokines produced by peritoneal macrophages contribute to the distinct clinical features of ovarian cancer, specifically malignant ascites and widespread peritoneal tumor implants [4,10,11].”
InfluentialOkła, K., Wertel, I., Polak, G., Surówka, J., Wawruszak, A., & Kotarski, J. (2016) · International Reviews of Immunology · doi:10.1080/08830185.2016.1206097 · Cited by 39
“Inhibition of IκB kinase β (IKKβ), a major activator of NFκB signaling, in ovarian TAMs prevented tumor cell invasion as well as decreased TAM production of M2 immunosuppressive cytokines and increased production of M1-associated IL-12 and NOS2 [105].”
BackgroundAi, R., Yan, T., Hao, Y., Jiang, L., Dan, H., Ji, N., Zeng, X. Y., Zhou, Y. J., & Chen, Q. (2017) · Oncotarget · doi:10.18632/oncotarget.20312 · Cited by 37
Goh, J., Niksirat, N., & Campbell, K. L. (2014) · Europe PMC (PubMed Central) · Cited by 35
Therapeutic targeting of tumor–stroma interactions
Hiscox, S., Barrett-Lee, P. J., & Nicholson, R. I. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561201 · Cited by 36
“The NF-kB pathway appears to play a key role in mediating TAM differentiation [97] and consequently, targeting NF-kB signaling in TAMs leads to their differentiation into a classical M1 phenotype that is cytotoxic to cancer cells with resulting regression of advanced cancers in vivo [98].”
BackgroundImplications of the tumor microenvironment on survival and disease response in follicular lymphoma
Gribben, J. G. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32833d5938 · Cited by 34
Wilson, A. J., Gupta, V. G., Liu, Q., Yull, F. E., Crispens, M. A., & Khabele, D. (2021) · Neoplasia · doi:10.1016/j.neo.2021.12.002 · Cited by 35
Advances in Bacterial Lysate Immunotherapy for Infectious Diseases and Cancer
Rahman, M. M., Grice, I. D., Ulett, G. C., & Wei, M. Q. (2024) · Journal of Immunology Research · doi:10.1155/2024/4312908 · Cited by 34
Wang, H., Yung, M. M. H., Yang, X., Chen, F., Chan, W., Siu, M. K. Y., Long, R., Jia, S., Liang, Y., Xu, D., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00558-8 · Cited by 35
Hoover, A., Hufnagel, D. H., Harris, W., Bullock, K. K., Glass, E. B., Liu, E., Barham, W. J., Crispens, M. A., Khabele, D., Giorgio, T. D., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-07450-8 · Cited by 34
Pankowska, K. A., Będkowska, G. E., Chociej-Stypułkowska, J., Rusak, M., Dąbrowska, M., & Osada, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119279 · Cited by 36
Macrophage and osteoclast polarization in bisphosphonate associated necrosis and osteoradionecrosis
Wehrhan, F., Möbius, P., Amann, K., Ries, J., Preidl, R. H. M., Neukam, F. W., & Weber, M. (2017) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2017.02.023 · Cited by 33
“NF-κB signaling is involved in the regulation of macrophage polarization leading to increased M2 polarization (Hagemann et al., 2008, Porta et al., 2009).”
BackgroundLiu, Y., Liu, F., Zeng, Y., Lin, L., Yu, H., Zhang, S., & Yang, W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1514595 · Cited by 33
Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets
Pan, D., Li, X., Qiao, X., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582305 · Cited by 39
Zou, P., Yuan, S., Yang, X. H., Guo, Y., Li, L., Xu, C., Zhai, X., & Wang, J. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.04.002 · Cited by 32
Pan, Y., Deng, L., Wang, H., He, K., & Xia, Q. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.07.015 · Cited by 34
Bilbao, M., Aikins, J. K., & Ostrovsky, O. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.12.033 · Cited by 34
Li, X., Zhu, S., Yin, P., Zhang, S., Xu, J., Zhang, Q., Shi, S., & Zhang, T. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1971797 · Cited by 32
“Furthermore, studies have shown that the decrease of M2TAMs can enhance the anti-tumor response mediated by T cells and improves the efficacy of immunotherapy (Hagemann et al., 2008; Jaiswal et al., 2010; Coussens et al., 2013).”
BackgroundCosta, E. S., Faiad, O. J., Landgraf, R. G., Ferreira, A. K., Brigatte, P., Curi, R., Cury, Y., & Sampaio, S. C. (2013) · Toxicon · doi:10.1016/j.toxicon.2013.08.057 · Cited by 32
“Studies have suggested that the appropriate activation of M1 macrophages or the conversion of M2 macrophages to M1 macrophages in tumours would be beneficial for cancer therapy (Watkins et al., 2007; Hagemann et al., 2008).”
BackgroundRoy, A., Chandra, S., Mamilapally, S., Upadhyay, P. K., & Bhaskar, S. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0756-y · Cited by 34
“Macrophage activation at the tumor site is associated with tumor regression as reported by earlier studies (44).”
BackgroundMacrophage targeting contributes to the inhibitory effects of embelin on colitis-associated cancer
Wu, T., Dai, Y., Wang, W., Teng, G., Jiao, H., Shuai, X., Zhang, R., Zhao, P., & Qiao, L. (2016) · Oncotarget · doi:10.18632/oncotarget.6969 · Cited by 34
“Mouse macrophages were derived as described elsewhere [14].”
BackgroundMethodTumor‐derived extracellular vesicles activate primary monocytes
Gärtner, K., Battke, C., Dünzkofer, J., Hüls, C., von Neubeck, B., Kellner, M. K., Fiestas, E., Fackler, S., Lang, S., & Zeidler, R. (2018) · Cancer Medicine · doi:10.1002/cam4.1465 · Cited by 32
“[28] demonstrated that NFκB signaling in TAMs is important for maintaining the M2 phenotype and promoting tumor growth.”
BackgroundMacrophages and NF-κB in Cancer
Lawrence, T. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_100 · Cited by 37
Self-citationHallmarks of perineural invasion in pancreatic ductal adenocarcinoma: new biological dimensions
Sun, Y., Jiang, W., Liao, X., & Wang, D. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1421067 · Cited by 37
Naik, P. A., Yeolekar, B. M., Qureshi, S., Yavuz, M., Huang, Z., & Yeolekar, M. A. (2025) · Advanced Theory and Simulations · doi:10.1002/adts.202401477 · Cited by 32
Bashir, S., Sharma, Y., Elahi, A., & Khan, F. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.02.011 · Cited by 33
“Arginase-1-expressing tumor-associated macrophages have also been observed to be transformed into tumorcytotoxic effector cells by molecular interference of inhibition of the nuclear factor NF-κB signaling [29].”
BackgroundHull, M. A., Cuthbert, R. J., Ko, C. W. S., Scott, D. J., Cartwright, E. J., Hawcroft, G., Perry, S., Ingram, N., Carr, I., Markham, A. F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06253-5 · Cited by 31
Ohashi, W., Hattori, K., & Hattori, Y. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225540 · Cited by 36
“By inhibition of nuclear factor–kB and signal transducer and activator of transcription 3, protumor macrophages become cytotoxic to tumor cells and promote regression of tumors in vivo (Kortylewski et al., 2005; Hagemann et al., 2008).”
BackgroundNF-κB: a mediator that promotes or inhibits angiogenesis in human diseases?
Jiang, Y., Zhang, J., Shi, C., Li, X., Jiang, Y., & Mao, R. (2023) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2023.20 · Cited by 31
The significance of macrophage phenotype in cancer and biomaterials
Bygd, H. C., Forsmark, K. D., & Bratlie, K. M. (2014) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0041-2 · Cited by 34
“Another target for reprogramming TAMS is the NFκB signaling pathway [64].”
Influence of the Tumor Microenvironment on Angiogenesis
Payne, S. J., & Jones, J. L. (2011) · Future Oncology · doi:10.2217/fon.11.13 · Cited by 32
Kamoshida, G., Matsuda, A., Sekine, W., Mizuno, H., Oku, T., Itoh, S., Irimura, T., & Tsuji, T. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.029 · Cited by 31
“Transcriptional regulator NF-jB-dependent signaling has also been shown to play an important role in the generation and maintenance of the immunosuppressive phenotypes of TAMs [23,24].”
BackgroundCD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy
Nip, C., Wang, L., & Liu, C. (2023) · Biomedicines · doi:10.3390/biomedicines11123326 · Cited by 33
“In addition, a separate melanoma study concluded that tumoral expression of CD200 similarly alters the tumor microenvironment by inhibiting IL-10 production from TAMCs [107].”
BackgroundTumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity
Njunge, L. W., Estania, A. P., Guo, Y., Liu, W., & Yang, L. (2020) · Theranostics · doi:10.7150/thno.45848 · Cited by 33
“Interestingly, the TPL2-/- macrophage phenotype is similar to that reported in TAMs with conditional deletion of IKKβ and macrophages expressing a dominant-negative IKKβ mutant [70].”
BackgroundMatsunaga, T., Saito, H., & Ikeguchi, M. (2011) · Institutional Repositories DataBase (IRDB) · Cited by 39
Liu, S., Du, Y., Shi, K., Yang, Y., & Yang, Z. (2019) · Europe PMC (PubMed Central) · Cited by 37
Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment
Heuvers, M. E., Aerts, J. G. J. V., Cornelissen, R., Groen, H. J. M., Hoogsteden, H. C., & Hegmans, J. P. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-580 · Cited by 34
“It has been shown that inhibiting IκB kinase (IKK) reprograms the M2 phenotype to the M1 subset [138,139].”
RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells
Soong, R.-S., Anchoori, R. K., Yang, B. K., Yang, A. D., Tseng, S.-H., He, L., Tsai, Y.-C., Roden, R. B. S., & Hung, C. (2016) · Oncotarget · doi:10.18632/oncotarget.12095 · Cited by 29
Tukaramrao, D. B., Korwar, A. M., Paulson, R. F., & Prabhu, K. S. (2017) · Advances in cancer research · doi:10.1016/bs.acr.2017.07.003 · Cited by 30
“TAMs are a major component of tumor infiltrates that are reprogrammed to be protumorigenic.”
BackgroundInfluentialStrategies for recruiting and targeting dendritic cells for optimizing HIV vaccines
Ahlers, J. D., & Belyakov, I. M. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.04.003 · Cited by 31
The JMJD Family Histone Demethylases in Crosstalk Between Inflammation and Cancer
Yang, J., Hu, Y., Zhang, B., Liang, X., & Li, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.881396 · Cited by 28
Role of macrophages in uveal melanoma
Herwig‐Carl, M. C., & Grossniklaus, H. E. (2011) · Expert Review of Ophthalmology · doi:10.1586/eop.11.45 · Cited by 31
The biological activity of macrophages in health and disease
Nazimek, K., & Bryniarski, K. (2012) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1004080 · Cited by 34
“IL-12 ma zdolność do reedukacji TAMs [76] oraz rekrutacji komórek NK wykazujących efekt cytotoksyczny [25], przez co może doprowadzić do ogólnoustrojowego nadmiernego wytwarzania IFN-g [27].”
BackgroundInfluentialBeatty, P. L., Cascio, S., & Finn, O. J. (2017) · Wiley eBooks · doi:10.1002/9781118468869.ch4 · Cited by 27
Inflammation and the coagulation system in tuberculosis: Tissue Factor leads the dance
Caccamo, N., & Dieli, F. (2016) · European Journal of Immunology · doi:10.1002/eji.201546225 · Cited by 28
NLRP3 ‐mediated periodontal ligament cell pyroptosis promotes root resorption
Li, X., Men, X., Ji, L., Chen, X., He, S., Zhang, P., & Chen, S. (2024) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13914 · Cited by 27
The metabolic addiction of cancer stem cells
Sahoo, O. S., Pethusamy, K., Srivastava, T. P., Talukdar, J., Alqahtani, M. S., Abbas, M. A. E., Dhar, R., & Karmakar, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.955892 · Cited by 26
Tan, X., Carretero, J., Chen, Z., Zhang, J., Wang, Y., Chen, J., Li, X., Ye, H., Tang, C., Cheng, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080885 · Cited by 30
Ye, X., Zhang, J., Lü, R., & Zhou, G. (2016) · Oncotarget · doi:10.18632/oncotarget.12874 · Cited by 26
“When NFκB signaling is repressed particularly in TAMs, they get to cytotoxic to tumor cells and switch to a “classically” activated phenotype [9].”
BackgroundCurrent progress in the inflammatory background of angiogenesis in gynecological cancers
Szewczyk, G., Maciejewski, T., & Szukiewicz, D. (2019) · Inflammation Research · doi:10.1007/s00011-019-01215-1 · Cited by 26
“NFκB signaling is also directly associated with TAMs; specific disruption of this pathway in ovarian cancer model leads toward inversion of TAMs phenotype back to the M1 population together with tumor regression [42].”
Dabrosin, N., Juul, K. S., Georgsen, J. B., Andrup, S., Schmidt, H., Steiniche, T., Øllegaard, T. H., & Bønnelykke‐Behrndtz, M. L. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000515 · Cited by 28
Lin, X., Fang, Y., Jin, X., Zhang, M., & Shi, K. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00461 · Cited by 25
Li, F., Zheng, X., Wang, X., Xu, J., & Zhang, Q. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101202 · Cited by 25
“To repolarize M2 into M1 phenotype is supposed to be therapeutic potential and will add up to the existing cancer therapies [10,12].”
BackgroundMichiba, A., Shiogama, K., Tsukamoto, T., Hirayama, M., Yamada, S., & Abe, M. (2022) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.22-00018 · Cited by 25
Kaminski, B. M., Weigert, A., Scherzberg, M.-C., Ley, S., Gilbert, B., Brecht, K., Brüne, B., Steinhilber, D., Stein, J. M., & Ulrich-Rückert, S. (2014) · APOPTOSIS · doi:10.1007/s10495-014-0988-x · Cited by 27
Girouard, J., Belgorosky, D., Hamelin-Morrissette, J., Boulanger, V., D'Orio, E., Ramla, D., Perron, R., Charpentier, L., Themsche, C. V., Eiján, A. M., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113778 · Cited by 25
Targeting signaling pathways with andrographolide in cancer therapy (Review)
Shaharudin, N. S., Singh, G. K. S., Kek, T., & Sultan, S. (2024) · Molecular and Clinical Oncology · doi:10.3892/mco.2024.2779 · Cited by 28
“…macrophages that aid in tissue repair processes and the expression of scavenger receptors, such as CD163, CD23 and CD206, to initiate various signaling pathways, such as the NF‑ κ B and PI3K/AKT/mTOR pathways, in the tumor microenvironment, including those that result in tumor progression (38,39).”
BackgroundMethodXiong, J., Zhou, X., Su, L., Jiang, L., Ming, Z., Pang, C., Fuller, C., Xu, K., Chi, H., & Zheng, X. (2024) · Discover Oncology · doi:10.1007/s12672-024-01464-5 · Cited by 24
Axl Involved in Mineral Trioxide Aggregate Induces Macrophage Polarization
Yeh, H.-W., Chiang, C., Chen, P.-H., Su, C.-C., Wu, Y., Chou, L., Huang, R., Liu, S.-Y., & Shieh, Y. (2018) · Journal of Endodontics · doi:10.1016/j.joen.2018.07.005 · Cited by 24
How Macrophages Become Transcriptionally Dysregulated: A Hidden Impact of Antitumor Therapy
Medvedeva, G. F., Kuzmina, D. O., Nuzhina, J., Shtil, A. A., & Dukhinova, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052662 · Cited by 24
Extracellular Vesicles (EVs) in Tumor Diagnosis and Therapy
Tan, M., Ge, Y., Wang, X., Wang, Y., Liu, Y., He, F., & Teng, H. (2023) · Technology in Cancer Research & Treatment · doi:10.1177/15330338231171463 · Cited by 30
Zimel, M. N., Horowitz, C. B., Rajasekhar, V. K., Christ, A. B., Wei, X., Wu, J., Wojnarowicz, P. M., Wang, D., Goldring, S. R., Purdue, P. E., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0995 · Cited by 25
“Based on functional characteristics, two types of macrophage phenotypes are categorized: (i) classically activated (M1) macrophages, which can display antitumor activity and (ii) alternatively activated (M2)macrophages, which have been associated with tumor-promoting functions (21, 22).”
Background
Metadata
- Authors
- Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R.
- Affiliations
- Queen Mary University of London (GB)
- 1Centre for Cancer and Inflammation
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-05-19
- Volume
- 205
- Issue
- 6
- Pages
- 1261-1268
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2413024
- OpenAlex
- W2105724560
- Cited by
- 792
- References
- 25
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 32 · 2023: 28 · 2022: 42 · 2021: 41 · 2020: 45 · 2019: 31 · 2018: 50 · 2017: 49 · 2016: 49 · 2015: 46 · 2014: 73 · 2013: 64 · 2012: 41
- FWCI
- 23.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Wellcome Trust
- Cancer Research UK
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- tumor-associated macrophages, NF-κB signaling, macrophage polarization, alternative macrophage activation, IκB kinase β, MyD88, interleukin-1 receptor, IL-12, NK cell recruitment, tumor immunosuppression, tumor microenvironment, antitumor immunity, tumor regression
- MeSH terms
- Animals, Cell Differentiation, Humans, Immunosuppression Therapy, Macrophages, Neoplasms, Phenotype, Signal Transduction, NF-kappa B, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.